An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
12 2019
Historique:
received: 24 01 2019
accepted: 30 05 2019
pubmed: 18 6 2019
medline: 2 5 2020
entrez: 18 6 2019
Statut: ppublish

Résumé

Biallelic pathogenic variants in the mismatch repair (MMR) genes cause a recessive childhood cancer predisposition syndrome known as constitutional mismatch repair deficiency (CMMRD). Family members with a heterozygous MMR variant have Lynch syndrome. We aimed at estimating cancer risk in these heterozygous carriers as a novel approach to avoid complicated statistical methods to correct for ascertainment bias. Cumulative colorectal cancer incidence was estimated in a cohort of PMS2- and MSH6-associated families, ascertained by the CMMRD phenotype of the index, by using mutation probabilities based on kinship coefficients as analytical weights in a proportional hazard regression on the cause-specific hazards. Confidence intervals (CIs) were obtained by bootstrapping at the family level. The estimated cumulative colorectal cancer risk at age 70 years for heterozygous PMS2 variant carriers was 8.7% (95% CI 4.3-12.7%) for both sexes combined, and 9.9% (95% CI 4.9-15.3%) for men and 5.9% (95% CI 1.6-11.1%) for women separately. For heterozygous MSH6 variant carriers these estimates are 11.8% (95% CI 4.5-22.7%) for both sexes combined, 10.0% (95% CI 1.83-24.5%) for men and 11.7% (95% CI 2.10-26.5%) for women. Our findings are consistent with previous reports that used more complex statistical methods to correct for ascertainment bias. These results underline the need for MMR gene-specific surveillance protocols for Lynch syndrome.

Identifiants

pubmed: 31204389
doi: 10.1038/s41436-019-0577-z
pii: S1098-3600(21)01215-6
doi:

Substances chimiques

DNA-Binding Proteins 0
G-T mismatch-binding protein 0
PMS2 protein, human EC 3.6.1.-
Mismatch Repair Endonuclease PMS2 EC 3.6.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2706-2712

Auteurs

Manon Suerink (M)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands. m.suerink@lumc.nl.

Mar Rodríguez-Girondo (M)

Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, Leiden, The Netherlands.

Heleen M van der Klift (HM)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.

Chrystelle Colas (C)

Department of Genetics, Institut Curie, Paris Sciences Lettres Research University, Paris, France.
Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Centre de Recherche Saint-Antoine, Paris, France.

Laurence Brugieres (L)

Child and Adolescent Cancer Department, Gustave Roussy Cancer Campus, Villejuif, France.

Noémie Lavoine (N)

Child and Adolescent Cancer Department, Gustave Roussy Cancer Campus, Villejuif, France.

Marjolijn Jongmans (M)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Gabriel Capellá Munar (GC)

Laboratori de Recerca Translacional, Catalan Institute of Oncology, Barcelona, Spain.

D Gareth Evans (DG)

Division of Evolution and Genomic Medicine, MAHSC, University of Manchester, St Mary's Hospital, Manchester, UK.

Michael P Farrell (MP)

Department of Cancer Genetics, Mater Private Hospital, Dublin, Ireland.

Maurizio Genuardi (M)

UOC Genetica Medica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy.

Yael Goldberg (Y)

The Raphael Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Israel.

Encarna Gomez-Garcia (E)

Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.

Karl Heinimann (K)

Research Group Human Genomics, Department of Biomedicine, University of Basel, and Medical Genetics, University Hospital Basel, Basel, Switzerland.

Jessica I Hoell (JI)

Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

Stefan Aretz (S)

Institute of Human Genetics, University of Bonn, Bonn, Germany.
Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.

Kory W Jasperson (KW)

Ambry Genetics, Aliso Viejo, CA, USA.

Inbal Kedar (I)

The Raphael Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Israel.

Mitul B Modi (MB)

Pennsylvania Hospital of University of Pennsylvania Health System, Philadelphia, PA, USA.
Gujarat Cancer & Research Institute, B.J.Medical College, Ahmedabad, India.

Sergey Nikolaev (S)

Inserm U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.

Theo A M van Os (TAM)

Department of Clinical Genetics, Amsterdam UMC, locatie AMC, Amsterdam, The Netherlands.

Tim Ripperger (T)

Department of Human Genetics, Hannover Medical School, Hannover, Germany.

Daniel Rueda (D)

Hereditary Cancer Laboratory, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain.

Leigha Senter (L)

The Ohio State University, Comprehensive Cancer Center, Division of Human Genetics, Columbus, USA.

Wenche Sjursen (W)

Department of Medical Genetics, St Olav University Hospital, Trondheim, Norway.
Norwegian University of Science and Technology, Trondheim, Norway.

Lone Sunde (L)

Department of Clinical Genetics, Aarhus University Hospital, Skejby, Denmark.

Christina Therkildsen (C)

The HNPCC Register, Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark.

Maria G Tibiletti (MG)

Department of Pathology, Ospedale di Circolo ASST Settelaghi, Varese, Italy.
Centro di Ricerca per lo studio dei tumori eredo-familiari, Università dell'Insubria, Varese, Italy.

Alison H Trainer (AH)

Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Yvonne J Vos (YJ)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Anja Wagner (A)

Department of Clinical Genetics, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Ingrid Winship (I)

Genomic Medicine, Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.

Katharina Wimmer (K)

Division of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.

Stefanie Y Zimmermann (SY)

Pediatric Hematology and Oncology, University Hospital, Frankfurt, Germany.

Hans F Vasen (HF)

Department of Gastroenterology & Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.

Christi J van Asperen (CJ)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.

Jeanine J Houwing-Duistermaat (JJ)

Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, Leiden, The Netherlands.

Sanne W Ten Broeke (SW)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Maartje Nielsen (M)

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH